行情

ZSAN

ZSAN

Zosano Pharma
NASDAQ

实时行情|Nasdaq Last Sale

0.5298
+0.0104
+2.00%
盘后: 0.5299 +0.0001 +0.02% 18:18 01/14 EST
开盘
0.5250
昨收
0.5194
最高
0.5399
最低
0.5110
成交量
66.66万
成交额
--
52周最高
3.060
52周最低
0.4605
市值
6,270.02万
市盈率(TTM)
-1.8364
分时
5日
1月
3月
1年
5年
Zosano Pharma Shares Spike; Co Announces Publication Of Clinical Data It Says Demonstrates Comparable Immunogenicity Of Trivalent Influenza Vaccine Formulated On Its Transdermal Microneedle System
Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the publication of Phase 1 clinical trial data in an article titled, "
Benzinga · 01/05 14:21
26 Stocks Moving in Tuesday's Pre-Market Session
Gainers
Benzinga · 2021/12/21 11:55
25 Stocks Moving in Monday's Pre-Market Session
Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index.
Benzinga · 2021/12/20 11:35
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Simply Wall St. · 2021/12/08 16:53
BRIEF-Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
reuters.com · 2021/11/30 08:15
“Zosano:从第 3 阶段到批准一流的偏头痛治疗” - 寻求贡献者的 Alpha 博客文章
https://seekingalpha.com/article/4265747-zosano-phase-3-approval-best-class-migraine-treatment
Benzinga · 2021/11/19 21:43
为了让 Covid 疫苗更容易服用,East Bay 公司推进微针贴片
With the pandemic claiming more than 5 million lives globally and vaccine uptake slow in some regions, several companies are looking for new ways to get Covid-treating drugs or vaccines to aptients more easily.
American City Business Journals · 2021/11/17 22:49
Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Nov. 17, 2021: TDOC, VRAR, ZSAN, RDW, SNDL
Today's 5 Stock Ideas: Teladoc (TDOC) - The company will host an investor day event on Thursday. The event will begin at 10 a.m. EST. Investor day events can often contain news catalysts and can lead to added
Benzinga · 2021/11/17 14:14
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解ZSAN最新的财务预测,通过ZSAN每股收益,每股净资产,每股现金流等数据分析Zosano Pharma近期的经营情况,然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

33.33%强力推荐
66.67%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测ZSAN价格均价为2.000,最高价位2.000,最低价为2.000。
最高2.000
均价2.000
最低2.000
现价0.5298
EPS
实际EPS
预期EPS
-0.08-0.06-0.04-0.02
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 45
机构持股: 1,301.51万
持股比例: 11.00%
总股本: 1.18亿
类型机构数股数
增持
10
35.55万
建仓
2
15.18万
减持
7
168.07万
平仓
6
6.75万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.51%
制药与医学研究
+0.11%
高管信息
President/Chief Executive Officer/Director
Steven Lo
Chief Financial Officer
Christine Matthews
Vice President
Donald Kellerman
Lead Director/Independent Director
Kenneth Greathouse
Director
Kathy McGee
Director
Elaine Yang
Independent Director
Steven Elms
Independent Director
Linda Grais
Independent Director
Joseph Hagan
暂无数据
ZSAN 简况
Zosano Pharma Corporation是一家临床阶段的生物制药公司。该公司专注于使用其真皮微针系统(以下简称“系统”)为患者提供系统性治疗。该系统旨在促进药物吸收到血液中。该公司的主要候选产品是Qtrypta(M207)。Qtrypta是利用其系统交付的佐米曲普坦制剂。佐米曲普坦是一种5-羟色胺受体激动剂,称为曲普坦,用于偏头痛的急性治疗。Qtrypta旨在将佐米曲普坦吸收到血液中,而不依赖胃肠道(GI)。其相同的配方,开发名称C213,用于缓解丛集性头痛。

微牛提供Zosano Pharma Corp(NASDAQ-ZSAN)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ZSAN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ZSAN股票基本功能。